Cargando…
Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer
BACKGROUND: Planar scintigraphy has long been indicated in patients receiving I-131 therapy for thyroid cancer to determine the anatomic location of metastases. We studied our experience upon implementing additional single-photon emission (SPECT)-CT scanning in these patients. METHOD: We performed a...
Autores principales: | Ahmadi, Sara, Coleman, Alexandra, de Morais, Nathalie Silva, Landa, Iñigo, Pappa, Theodora, Kang, Alex, Kim, Matthew I, Marqusee, Ellen, Alexander, Erik K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175585/ https://www.ncbi.nlm.nih.gov/pubmed/35521806 http://dx.doi.org/10.1530/EC-21-0371 |
Ejemplares similares
-
SPECT/CT-based dosimetry of salivary glands and iodine-avid lesions following (131)I therapy
por: Abuqbeitah, Mohammad, et al.
Publicado: (2023) -
Leukaemias and cancers following iodine-131 administration for thyroid cancer.
por: de Vathaire, F., et al.
Publicado: (1997) -
Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience
por: Verma, Priyanka, et al.
Publicado: (2012) -
Point of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment
por: Ahmadi, Sara, et al.
Publicado: (2022) -
Evaluation of Iodine-123 and Iodine-131 SPECT activity quantification: a Monte Carlo study
por: Morphis, Michaella, et al.
Publicado: (2021)